Role of reverse remodelling in recurrence of atrial fibrillation after patient-tailored catheter ablation
Europace · 02.11.2026
DOI: 10.1093/europace/euag312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 02.11.2026. Verfasst von George Teodor Obada und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, United Kingdom. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aims Catheter ablation (CA) is a curative treatment for atrial fibrillation (AF), yet success rates remain sub-optimal, with ∼50% of patients with persistent AF experiencing recurrence after 1 year. This may be due to the self-perpetuating nature of AF, which remodels atrial structure and cellular properties, while successful treatment can induce reverse remodelling (RR). This study develops a patient-specific CA strategy to directly target re-entrant drivers (RDs) and investigates the role of RR in AF recurrence.
Methods
Left atrial (LA) models were reconstructed from LGE-MRI scans of AF patients (n = 15) and coupled with the Courtemanche-Ramirez-Nattel (CRN) electrophysiology model. RDs were induced via pacing, identified using DGM analysis, and targeted ablation was performed in-silico. Pulmonary vein isolation (PVI) was applied as a reference. Following termination, AF recurrence was tested under three levels of electrical reverse remodelling (ERR: 0%, 50%, and 100%), with and without structural reverse remodelling (SRR).
Results
Targeted ablation acutely terminated AF in all patient-specific models. After the first procedure, AF recurrence decreased progressively from 55% at 0% ERR to 36.7% at 50% ERR and 5% at 100% ERR; with additional SRR, recurrence was further reduced to 46.7%, 26.7%, and 0%, respectively. After the second CA procedure, AF recurrence rate was 42.9%, 17.9%, and 0% without SRR and 25%, 14.3%, and 0% with SRR.
Conclusion
This study highlights the importance of RR for therapy success, with a novel targeted CA technique ensuring <5% AF recurrence in patient-specific simulations. After clinical validation, this approach can help improve long-term patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, United Kingdom.
- Department of Physics and Astronomy, Ghent University, Ghent, Belgium.
ORCID-Profile: George Teodor Obada, Shaheim Ogbomo-Harmitt, Maria Deprez, Nele Vandersickel
Zitieren
APA
Obada, G. T., Ogbomo-Harmitt, S., Deprez, M., Vandersickel, N., & Aslanidi, O. (2026). Role of reverse remodelling in recurrence of atrial fibrillation after patient-tailored catheter ablation. Europace. https://doi.org/10.1093/europace/euag312
Vancouver
Obada GT, Ogbomo-Harmitt S, Deprez M, Vandersickel N, Aslanidi O. Role of reverse remodelling in recurrence of atrial fibrillation after patient-tailored catheter ablation. Europace. 2026. doi:10.1093/europace/euag312
BibTeX
@article{Obada2026,
author = {Obada, George Teodor and Ogbomo-Harmitt, Shaheim and Deprez, Maria and Vandersickel, Nele and Aslanidi, Oleg},
title = {Role of reverse remodelling in recurrence of atrial fibrillation after patient-tailored catheter ablation},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag312}
}
EUVIMED